nach oben

Erschienen in:

01.06.2012 | Original Article

Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern

verfasst von: Reza Saghiri, Niloufar Ghashghai, Shafieh Movaseghi, Pegah Poursharifi, Shohreh Jalilfar, Manijeh Ahmadi Bidhendi, Leila Ghazizadeh, Mina Ebrahimi-Rad

Erschienen in: Rheumatology International | Ausgabe 6/2012

Einloggen, um Zugang zu erhalten

Abstract

Adenosine deaminase (ADA) plays a crucial role in the development and maintenance of normal immune system. So, any immunological imbalances could associate with its altered activity in serum. This study evaluated the activity of total ADA and its isoenzymes in serum of 45 patients with systemic lupus erythematosus (SLE). Included were 23 patients with active SLE, 22 during the inactive phase of the disease, and 45 healthy subjects. Our results provided evidence that the significantly elevated total ADA activity in serum of SLE patients is correlated mainly with the increased ADA2 level. The highest mean ADA2 activity during the relapse phase of the disease could be an indication to the macrophages, the main source of ADA2. It might be concluded that ADA and its isoenzymes analysis in serum of patients could be used as a useful and non-invasive diagnostic tool in evaluation of SLE active phase and the disease severity.

Van Der Weyden MB, Kelley WN (1976) Human adenosine deaminase: distribution and properties. J Biol Chem 251:5448–5456PubMed

Ali M, Sari R, E Bakan (2002) Serum adenosine deaminase and cytidine deaminase activities in patients with systemic lupus erythematosus. Clin Chem Lab Med 40:493–495CrossRef

Giblett ER, Anderson JE, Cohen F, Pollara B, Meuwissen HJ (1972) Adenosine deaminase deficiency in two patients with severe impaired cellular immunity. Lancet 2:1067–1069PubMedCrossRef

Tsuboi I, Sagawa K, Shichijo S, Yokoyama MM, Ou DW, Wiederhold MD (1995) Adenosine deaminase isoenzyme levels in patients with human T-cell lymphotropic virus type 1 and human immunodeficiency virus type 1 infection. Clin Diagn Lab Immunol 2:626–630PubMed

Ratech H, Kuritsky L, Thorbecke GJ, Hirschhorn R. (1982) Suppression of human lymphocyte DNA and protein synthesis in vitro by adenosine and eight modified adenine nucleosides in the presence or in the absence of adenosine deaminase inhibitors, 2′-deoxycoformycin (DCF) and erythro-9-(2-hydroxy-3-nonyl) adenine (EHNA). Cell Immunol 68: 244–51

Salvatore D, Claudio MM, Anna PM (1987) Adenosine deaminase activity and Acquired Immunodeficiency Syndrome (AIDS). Clin Chem 33:1675

Poursharifi P, Saghiri R, Ebrahimi-Rad M, Nazem H, Pourpak Z, Moin M, Shams S (2009) Adenosine deaminase in patients with primary immunodeficiency syndromes: the analysis of serum ADA1 and ADA2 activities. Clin Biochem 42:1438–1443PubMedCrossRef

Iwaki-Egawa S, Watanabe Y, Matsuno H (2001) Correlations between matrix metalloproteinase-9 and adenosine deaminase isoenzymes in synovial fluid from patients with Rheumatoid Arthritis. J Reumatol 28:485–489

Chiba S, Saitoh M, Kashiwagi M, Kobayashi N, Matsumoto H (1995) Isozyme analysis of the high serum adenosine deaminase activity in patients with Myasthenia Gravis. Intern Med 34:81–84PubMedCrossRef

10.

Andreasyan NA, Hairapetian HL, Sargisova YG, Mardanyan SS, Badalyan LT, Khanoyan AS (2001) Activity of adenosine deaminase and its isoforms in pleural fluid in tuberculous pleuritis. Med Sci Monit 8:708–712

11.

Hirshhorn R, Ratech H (1980) Current topics in biological and medical research. New York. 131–57

12.

Vasudha KC, Nirmalkumar A, Venkatesh T (2006) Studies on the age dependent changes in serum adenosine deaminase activity and its changes in Hepatitis. Indian Clin Biochem 21:116–120CrossRef

13.

Muraoka T, Katsuramaki T, Shiraishi H, Yokoyama MM (1990) Automated enzymatic measurement of adenosine deaminase is enzyme activities in serum. Anal Biochem 187:268–272PubMedCrossRef

14.

Gan TE, Daddona PE, Mitchell BS (1987) Genetic expression of adenosine deaminase in human lymphoid malignancies. Blood 69:1376–1380PubMed

15.

Yuksel H, Akoglu TF (1988) Serum and synovial fluid adenosine deaminase activity in patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis 47:492–495PubMedCrossRef

16.

Koizumi H, Ohkawara A (1992) Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia. Acta Derm Venerol 72:410–412PubMed

17.

Steinberg AD, Klinman DM (1988) Pathogenesis of systemic lupus erythematosus. Rheum Dis Clin North Am 13:25–29

18.

Tan EM (1989) Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol 44:93–151PubMedCrossRef

19.

Samsonov MY, Tilz GP, Egorova O (1995) Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus 4:29–32PubMedCrossRef

20.

Laxminarayana D, O’Rourke KS, Maas S, Olorenshaw I (2007) Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes. Immunology 121:359–369PubMedCrossRef

21.

Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D (2001) Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 20:411–416PubMedCrossRef

22.

Stancikova M, Lukac J, Istok R, Cristalli G, Rovensky J (1998) Serum adenosine deaminase activity and its isoenzymes pattern in patients with systemic lupus erythematosus. Clin Exp Rheumatol 15:583–586

23.

Davas EM, Tsirogianna A, Kappou I, Karamitsos D, Economidou I, Dantis PC (1999) Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 18:17–22PubMedCrossRef

24.

Mahmoud RA, El-Gendi HI, Ahmed HH (2005) Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (P75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 38:134–141PubMedCrossRef

25.

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRef

26.

Ellis G, Goldberg DM (1970) A reduced nicotinamide adenine dinucleotide-linked kinetic assay for adenosine deaminase activity. J Lab Clin Med 76:507–517PubMed

27.

Heinz F (1984) Methods of enzymatic analysis. Verlag Chemie:Weinheim, New York, pp 315–323

28.

Muraoka T, Katsuramaki T, Shiraishi H, Yokoyama MM (1990) Automated enzymatic measurement of adenosine deaminase is enzyme activities in serum. Anal Biochem 187:268–272PubMedCrossRef

29.

Lorenz HM, Herrmann M, Winkler T, Gaipl U, Kalden JR (2000) Role of apoptosis in autoimmunity. Apoptosis 5:443–449PubMedCrossRef

30.

Aldrich MB, Blackburn MR, Kellems RE (2000) The importance of adenosine deaminase for lymphocyte development and function. Biochem Biophy Res Comm 272:311–315CrossRef

31.

Meunier P, Filipe P, Emerit I, Freitas J, Guerra Rodrigo F, Manso C (1995) Adenosine deaminase in progressive systemic sclerosis. Acta Derm Venerol 75:297–299PubMed

32.

Valdes L, San Jose E, Alvarez D, Valle JM (1996) Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: Diagnostic role and relevance to the origin of increased ADA in tuberculous pleurisy. Eur Respir J 9:747–751PubMedCrossRef

33.

Storch H, Krüger W, Rotzsch W (1981) Adenosine deaminase activity in plasma and blood cells of patients with haematological and autoimmune diseases. Acta Haematol 65:183–188PubMedCrossRef

34.

Nalini G, Hariprasad C, Chandrase-Karan AN, Poonguzhali K (1993) A comparative study of serum adenosine deaminase in systemic rheumatic disease. Br J Rheumatol 32:1118–1119PubMedCrossRef

35.

Lamsal M, Gautam N, Bhatta N, Majhi S, Baral N, Bhattacharya SK (2007) Diagnostic utility of adenosine deaminase (ADA) activity in pleural fluid and serum of tuberculous and non-tuberculous respiratory disease patients. Southeast Asian J Trop Med Public Health 38:363–369PubMed

36.

Kose K, Yazici C, Assioglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet’s disease. Clin Biochem 34:125–129PubMedCrossRef

37.

Ratech H, Martiniuk F, Borer WZ, Rappaport H (1988) Differential expression of adenosine deaminase isozymes in acute leukemia. Blood 72:1627–1632PubMed

38.

Shibagaki T, Hasegawa Y, Saito H, Yamori S, Shimokata K (1996) Adenosine deaminase isoenzymes in tuberculous pleural effusion. J Lab Clin Med 127:348–352PubMedCrossRef

39.

Ungerer JP, Oosthuizen HM, Retief JH, Bissbort SH (1994) Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest 106:33–37PubMedCrossRef

40.

Valdes L, Pose A, San Jose E, Martinez Vazquez JM (2003) Tuberculous pleural effusions. Eur J Intern Med 14:77–88PubMedCrossRef

41.

Jin O, Sun LY, Zhou KX, Zhang XS, Feng XB, Mok MY, Lau CS (2005) Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus. Clin Rheumatol 24:107–110PubMedCrossRef

42.

Mevorach D (2003) Systemic lupus erythematosus and apoptosis: a question of balance. Clin Rev Allergy Immunol 25:49–60PubMedCrossRef

43.

Distler JH, Huber LC, Hueber AJ, Reich CF 3rd, Gay S, Distler O, Pisetsky DS (2005) The release of microparticles by apoptotic cells and their effects on macrophages. Apoptosis 10:731–741PubMedCrossRef

44.

Kozyr AV, Kolesnikov AV, Zelenova NA, Sashchenko LP, Mikhalap SV, Bulina ME, Ignatova AN, Favorov PV, Gabibov AG (2000) Autoantibodies to nuclear antigens: correlation between cytotoxicity and DNA-hydrolyzing activity. Appl Biochem Biotechnol 83:255–269PubMedCrossRef

45.

Shoshan Y, Shapira I, Toubi E, Frolkis I, Yaron M, Mevorach D (2001) Accelerated Fas-mediated apoptosis of monocytes and maturing macrophages from patients with systemic lupus erythematosus: relevance to in vitro impairment of interaction with iC3b-opsonized apoptotic cells. J Immunol 167:5963–5969PubMed

46.

Mevorach D, Mascarenhas JO, Gershov D, Elkon KB (1998) Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188:2313–2320PubMedCrossRef

47.

Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330PubMedCrossRef

48.

Conlon BA, Law WR (2004) Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses. Clin Exp Immunol 138:14–20PubMedCrossRef

Titel: Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern
verfasst von: Reza Saghiri
Niloufar Ghashghai
Shafieh Movaseghi
Pegah Poursharifi
Shohreh Jalilfar
Manijeh Ahmadi Bidhendi
Leila Ghazizadeh
Mina Ebrahimi-Rad
Publikationsdatum: 01.06.2012
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 6/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-011-1836-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2012

Survival in progressive systemic sclerosis with pulmonary involvement: a single-center experience in Istanbul, Turkey

Tuberculosis as a risk factor for systemic lupus erythematosus: results of a nationwide study in Taiwan

Effects of pulsed electromagnetic fields on the mRNA expression of CAII and RANK in ovariectomized rats

Analysis of the classical, alternative, and mannose binding lectin pathway of the complement system in the pathogenesis of oligoarticular juvenile idiopathic arthritis

Calcium metabolism disorders simulating rheumatologic diseases

Recurrence of severe low back pain due to myeloproliferative disorder in a patient affected by seronegative spondyloarthropathy

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Metformin rückt in den Hintergrund

Myokarditis nach Infekt – richtig schwierig wird es bei Profisportlern

Thrombophiliescreening – Wenn, dann richtig und nur bei therapeutischer Konsequenz

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Update Innere Medizin